These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16106723)

  • 1. [Cost analysis in patients admitted with COPD in 2002].
    Strâmbu I; Bucşa S; Nicolescu D; Dumitrescu C; Grigorescu B; Stoicescu IP
    Pneumologia; 2004; 53(4):161-8. PubMed ID: 16106723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct medical costs of COPD--an excess cost approach based on two population-based studies.
    Menn P; Heinrich J; Huber RM; Jörres RA; John J; Karrasch S; Peters A; Schulz H; Holle R;
    Respir Med; 2012 Apr; 106(4):540-8. PubMed ID: 22100535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
    Miravitlles M; Sicras A; Crespo C; Cuesta M; Brosa M; Galera J; Lahoz R; Lleonart M; Riera MI
    Ther Adv Respir Dis; 2013 Jun; 7(3):139-50. PubMed ID: 23653458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
    Jahnz-Rózyk K; Targowski T; From S
    Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost analysis for inpatient therapy for patients with acute exacerbations of chronic obstructive pulmonary disease].
    Motegi T; Yamada K; Kida K
    Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):787-94. PubMed ID: 17144574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
    Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
    Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dynamic population model of disease progression in COPD.
    Hoogendoorn M; Rutten-van Mölken MP; Hoogenveen RT; van Genugten ML; Buist AS; Wouters EF; Feenstra TL
    Eur Respir J; 2005 Aug; 26(2):223-33. PubMed ID: 16055869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare costs of COPD in Italian referral centres: a prospective study.
    Koleva D; Motterlini N; Banfi P; Garattini L;
    Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors contributing to high-cost hospital care for patients with COPD.
    Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Przegl Lek; 2004; 61(10):1049-51. PubMed ID: 15794248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease.
    Chen YH; Yao WZ; Cai BQ; Wang H; Deng XM; Gao HL; Huang JS; Wang XM
    Chin Med J (Engl); 2008 Apr; 121(7):587-91. PubMed ID: 18466676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Admission for syncope: evaluation, cost and prognosis according to etiology.
    Shiyovich A; Munchak I; Zelingher J; Grosbard A; Katz A
    Isr Med Assoc J; 2008 Feb; 10(2):104-8. PubMed ID: 18432020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.